For instances, CCL19 could suppress tumor angiogenesis by promoting miR-206 expression dependently on CCR7, and thereby inhibiting the Met/ERK/Elk-1/HIF-1α/VEGF-A pathway. Here, CCL19 is linked to neoplasm.